title: The Risky Business of Drug Development: The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey - As Illustrated By The Decisions Of Germany's Gemeinsamer Bundesausschuss (G-Ba).
authors.affiliation: Berlikon LLC, Chapel Hill, NC, USA.
authors.forename: A
authors.initials: A
authors.lastname: Maetzel
authors.affiliation: Roche Pharma, Grenzach-Wyhlen, Germany.
authors.forename: T R
authors.initials: TR
authors.lastname: Staab
authors.affiliation: Roche Pharma, Grenzach-Wyhlen, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Ruof